Cadila Healthcare submits press release

05 Dec 2019 Evaluate

Cadila Healthcare has informed about submission of a copy of press release dated December 5, 2019 titled ‘Zydus announces regulatory filing of Saroglitazar Magnesium for treatment of NASH with DCGI’. The contents of the press release give full details. 

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

934.50 -10.65 (-1.13%)
18-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1523.80
Dr. Reddys Lab 5959.10
Cipla 1352.95
Zydus Lifesciences 934.50
Lupin 1599.65
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.